EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

HSPiP-QbD Enabled Optimized Tolterodine Lipid Nanoparticles with GastroPlus-Based in vivo Prediction and in vivo Studies for Controlled Drug Delivery

Afzal Hussain, Thomas J Webster, Mohd Usman Mohd Siddique, Mohhammad Ramzan

International Journal of Nanomedicine · 2026-11 · Volume 21 · 1-29

DOI: 10.2147/ijn.s632752 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Nanomedicine, 2026-11. Verfasst von Afzal Hussain und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Hussain, A., Webster, T. J., Siddique, M. U. M., & Ramzan, M. (2026). HSPiP-QbD Enabled Optimized Tolterodine Lipid Nanoparticles with GastroPlus-Based in vivo Prediction and in vivo Studies for Controlled Drug Delivery. International Journal of Nanomedicine, Volume 21, 1-29. https://doi.org/10.2147/ijn.s632752

Vancouver

Hussain A, Webster TJ, Siddique MUM, Ramzan M. HSPiP-QbD Enabled Optimized Tolterodine Lipid Nanoparticles with GastroPlus-Based in vivo Prediction and in vivo Studies for Controlled Drug Delivery. International Journal of Nanomedicine. 2026;Volume 21:1-29. doi:10.2147/ijn.s632752

BibTeX
@article{Hussain2026,
  author = {Hussain, Afzal and Webster, Thomas J and Siddique, Mohd Usman Mohd and Ramzan, Mohhammad},
  title = {HSPiP-QbD Enabled Optimized Tolterodine Lipid Nanoparticles with GastroPlus-Based in vivo Prediction and in vivo Studies for Controlled Drug Delivery},
  journal = {International Journal of Nanomedicine},
  year = {2026},
  volume = {Volume 21},
  pages = {1--29},
  doi = {10.2147/ijn.s632752}
}
Kostenlos starten →